Poehling Capital Management, Inc. Oncocyte Corp Transaction History

Poehling Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$2.2 - $3.45 $110 - $172	-50 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$2.0 - $3.3 $100 - $165	50 New	50 $0
Q1 2018 May 14, 2018	SELL	$1.25 - $4.6 $62 - $229	-50 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$3.9 - $7.4 $195 - $370	50	50 $0

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $247M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Poehling Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Poehling Capital Management, Inc. with notifications on news.